======= PAGR1 =======
== Gene Information ==
* **Official Symbol**: PAGR1
* **Official Name**: PAXIP1 associated glutamate rich protein 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=79447|79447]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9BTK6|Q9BTK6]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=PAGR1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PAGR1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/612033|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Its association with the histone methyltransferase MLL2/MLL3 complex is suggesting a role in epigenetic transcriptional activation. However, in association with PAXIP1/PTIP is proposed to function at least in part independently of the MLL2/MLL3 complex. Proposed to be recruited by PAXIP1 to sites of DNA damage where the PAGR1:PAXIP1 complex is required for cell survival in response to DNA damage independently of the MLL2/MLL3 complex (PubMed:19124460). However, its function in DNA damage has been questioned (By similarity). During immunoglobulin class switching in activated B-cells is involved in transcription regulation of downstream switch regions at the immunoglobulin heavy-chain (Igh) locus independently of the MLL2/MLL3 complex (By similarity). Involved in both estrogen receptor-regulated gene transcription and estrogen-stimulated G1/S cell-cycle transition (PubMed:19039327). Acts as transcriptional cofactor for nuclear hormone receptors. Inhibits the induction properties of several steroid receptors such as NR3C1, AR and PPARG; the mechanism of inhibition appears to be gene-dependent (PubMed:23161582). {ECO:0000250|UniProtKB:Q99L02, ECO:0000269|PubMed:19039327, ECO:0000269|PubMed:19124460, ECO:0000269|PubMed:23161582, ECO:0000305}.
No Pfam Domain information is available for this gene.
|positive regulation of intracellular estrogen receptor signaling pathway|
|MLL3/4 complex|
|positive regulation of intracellular steroid hormone receptor signaling pathway|
|histone H3-K4 methylation|
|regulation of intracellular estrogen receptor signaling pathway|
|histone methyltransferase complex|
|estrogen receptor binding|
|positive regulation of cell cycle G1/S phase transition|
|histone lysine methylation|
|regulation of intracellular steroid hormone receptor signaling pathway|
|peptidyl-lysine methylation|
|histone methylation|
|positive regulation of cell cycle phase transition|
|protein methylation|
|protein alkylation|
|regulation of cell cycle G1/S phase transition|
|DNA recombination|
|macromolecule methylation|
|positive regulation of cell cycle process|
|methylation|
|peptidyl-lysine modification|
|histone modification|
|covalent chromatin modification|
|positive regulation of cell cycle|
|regulation of cell cycle phase transition|
|DNA repair|
|chromatin organization|
|DNA metabolic process|
|regulation of cell cycle process|
|cellular response to DNA damage stimulus|
|peptidyl-amino acid modification|
|chromosome organization|
|regulation of cell cycle|
|positive regulation of transcription by RNA polymerase II|
|positive regulation of transcription, DNA-templated|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|positive regulation of signal transduction|
|cellular response to stress|
|positive regulation of RNA metabolic process|
|positive regulation of cell communication|
|positive regulation of signaling|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
No hits were found.
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 25/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|2/28|
|bone|0/25|
|breast|2/33|
|central nervous system|1/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|1/15|
|kidney|1/21|
|liver|2/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|2/24|
|soft tissue|1/7|
|thyroid|0/2|
|upper aerodigestive|3/22|
|urinary tract|2/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 2618
* **Expression level (log2 read counts)**: 6.26
{{:chemogenomics:nalm6 dist.png?nolink |}}